ESR1 and neoplasm: Prognostic factors, i.e., those that predict the risk of recurrence or death from breast cancer, include stage, number of positive axillary nodes, tumor size, lymphatic and vascular invasion, the estrogen-receptor (ER) and progesterone-receptor (PR) positivity, and HER2/neu gene amplification [3,5].